148P HexaBody-OX40: A novel Fcγ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo
K. Kemper, M. Köhne, M. van der Kroef, K. Nuermberger, M. Russier, G. Zom, Anna-Lena Krause, P. de Goeje, F. Gieseke, A. Gorlani, A. Muik, L. Guelen, D. Satijn, S. Fellermeier-Kopf, T. Ahmadi, Ö. Türeci, E. Breij, U. Şahin
{"title":"148P HexaBody-OX40: A novel Fcγ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo","authors":"K. Kemper, M. Köhne, M. van der Kroef, K. Nuermberger, M. Russier, G. Zom, Anna-Lena Krause, P. de Goeje, F. Gieseke, A. Gorlani, A. Muik, L. Guelen, D. Satijn, S. Fellermeier-Kopf, T. Ahmadi, Ö. Türeci, E. Breij, U. Şahin","doi":"10.1016/j.iotech.2023.100620","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 31","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100620","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
